Cartilago develops disease-modifying, chondroprotective technologies for combating osteoarthritis and related pathologies.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City: Maglie
State: Puglia
Zip:
Country: Italy
Cartilago develops disease-modifying, chondroprotective technologies for combating osteoarthritis and related pathologies. They directly target the pathophysiology of the disease to provide not only symptomatic relief but also to impede the disease&s;s regular natural development. Additional indications are being addressed by the adaptation of their technology, such as anti-aging treatments, wound care, and cancer anti-metastatic therapy.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2020 | Pre Seed Round | 1 | $255.1k |
CDP Equity CDP Equity |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|